FDA Advisers Reject Desmopressin for NocturiaFDA Advisers Reject Desmopressin for Nocturia

Panelists said the benefit did not outweigh the risks, and that there were too many unanswered questions about safety and efficacy. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Urology News Source Type: news